Webinar live date: Wednesday 2nd September 2020 07:00 [PDT] 10:00 [EDT] 15:00 [BST]. This webinar will discuss the applications of ELISpot assays to detect cellular immune responses to specific antigens associated with viral vector-based gene therapies.

Webinar available on demand. Bioanalysis Zone is delighted to offer its members unique access to this panel discussion. The panel discussion focuses on new methods, the new age of biomarkers and current trends in non-standard bioanalytical techniques.

Webinar available on demand. This webinar will discuss how multi-parameter flow cytometry can be used to confidently detect, characterizeand quantitate rare-cell populations for clinical development applications.

Webinar available on demand. Join us for an in-depth bioanalytical and clinical exploration, including case studies, of microsampling technology and its significance in supporting patient-centric healthcare initiatives.

Webinar available on demand. In this webinar, we will investigate ligand binding assays (LBAs) and LC–MS/MS generic PK methods for the quantification of therapeutic monoclonal antibodies in pre-clinical species.

Panel discussion available on demand. In this free panel discussion, our experts will provide insights into their own research and involvement with biomarker discovery including the challenges they have had to overcome, key trends they have seen and their future outlook on the development of this field.

Webinar available on demand. Learn how LC–MS/MS targeted quantification approaches can provide the highest possible sensitivity and selectivity for host cell proteins for biotherapeutic production.

Webinar available on demand. As COVID-19 is shutting down countries, particularly locking down travel, we discuss the impact on blood sample collection and how a patient-centric sampling approach could help mitigate these challenges and how the approach could be part of our new normal.

Webinar available on demand. Development and optimization of a fit-for-purpose, fully qualified biotherapeutic PK assay on a microfluidic, automated immunoassay platform enhances workflow efficiency and minimizes human error.

Webinar available on demand. With the ongoing COVID-19 pandemic extensively impacting clinical trials irrespective of indication, learn how bioequivalence studies (BCS) can be a suitable stop-gap measure in the interim.